Single-Domain Antibodies Tackle Covid Variants

NATURE（2021）

引用 8|浏览8

暂无评分

摘要

Camels and llamas make antibodies that bind to targets using small, 'nanobody' protein domains. Mice have now been engineered to make nanobodies that might be more effective than conventional antibodies in treating COVID-19.

查看译文

关键词

Immunology,Medical research,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要